126 related articles for article (PubMed ID: 26981890)
1. Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients.
Ham JY; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD; Won DI; Song KE; Cho JH
Scand J Clin Lab Invest; 2016 Jul; 76(4):296-303. PubMed ID: 26981890
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
[TBL] [Abstract][Full Text] [Related]
3. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma.
Vergara Chozas JM; Sáez-Benito Godino A; Zopeque García N; García Pinteño S; Joumady I; Carrasco García C; Vara Gil F
Transplant Proc; 2012 Nov; 44(9):2669-72. PubMed ID: 23146489
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PETINIA and LC-MS/MS for determining plasma mycophenolic acid concentrations in Japanese lung transplant recipients.
Kikuchi M; Tanaka M; Takasaki S; Takahashi A; Akiba M; Matsuda Y; Noda M; Hisamichi K; Yamaguchi H; Okada Y; Mano N
J Pharm Health Care Sci; 2018; 4():7. PubMed ID: 29619240
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mycophenolic acid concentrations determined by a new PETINIA assay on the dimension EXL analyzer and a HPLC-UV method.
Dasgupta A; Tso G; Chow L
Clin Biochem; 2013 May; 46(7-8):685-7. PubMed ID: 23219740
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients.
Jung HY; Lee S; Jeon Y; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
J Korean Med Sci; 2020 Jun; 35(24):e185. PubMed ID: 32567256
[TBL] [Abstract][Full Text] [Related]
8. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
9. Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies.
Md Dom ZI; Noll BD; Coller JK; Somogyi AA; Russ GR; Hesselink DA; van Gelder T; Sallustio BC
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():171-7. PubMed ID: 24342510
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application.
Kocur A; Rubik J; Czarnowski P; Czajkowska A; Marszałek D; Sierakowski M; Górska M; Pawiński T
Pharmacol Rep; 2023 Aug; 75(4):1026-1042. PubMed ID: 37452967
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
[TBL] [Abstract][Full Text] [Related]
12. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
Kaplan B
Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients.
Zegarska J; Hryniewiecka E; Żochowska D; Tszyrsznic W; Jaźwiec R; Borowiec A; Pawłowska E; Dadlez M; Pączek L
Ann Transplant; 2015 Aug; 20():483-92. PubMed ID: 26313036
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a Point-of-Care Testing with Enzyme-Multiplied Immunoassay Technique and Liquid Chromatography Combined With Tandem Mass Spectrometry Methods for Therapeutic Drug Monitoring of Mycophenolic Acid: A Preliminary Study.
Zhou H; Xiang H; Cai J; Wang Y; Zhang M; Han Y; Zhang Y
Ther Drug Monit; 2021 Oct; 43(5):630-636. PubMed ID: 33394991
[TBL] [Abstract][Full Text] [Related]
17. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
[TBL] [Abstract][Full Text] [Related]
18. Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Kuhn J; Götting C; Kleesiek K
Talanta; 2010 Mar; 80(5):1894-8. PubMed ID: 20152429
[TBL] [Abstract][Full Text] [Related]
19. Mathematical equations to calculate true mycophenolic acid concentration in human plasma by using two immunoassays with different cross-reactivities with acyl glucuronide metabolite: comparison of calculated values with values obtained by using an HPLC-UV method.
Dasgupta A; Johnson M; Tso G
J Clin Lab Anal; 2013 Jul; 27(4):290-3. PubMed ID: 23852786
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of two techniques of mycophenolate mofetyl monitoring.
Jebabli N; Gaïes E; Charfi R; El Jebari H; Ben Sassi M; Salouage I; Daghfous R; Trabelsi S
Tunis Med; 2019; 97(8-9):1010-1016. PubMed ID: 32173850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
